Key result
Circulating biomarkers show promise for early stroke diagnosis but lack an established clinical panel.
Why the study?
Current diagnostic methods do not allow optimal early diagnosis and differentiation between ischemic and hemorrhagic stroke, hindering timely and appropriate treatment.
-
No takes yet. Share an insight, caveat, or question.
Shiraliyeva et al. (2013) conducted a review in Stroke. Biochemical markers was evaluated. Biochemical markers show potential for early and differential diagnosis of stroke, though an optimal single marker or panel for routine clinical practice has not yet been established.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: